Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nice Ltd

147.07
+3.272.27%
Post-market: 147.070.00000.00%19:59 EDT
Volume:320.32K
Turnover:46.90M
Market Cap:9.30B
PE:21.76
High:147.91
Open:144.35
Low:144.10
Close:143.80
Loading ...

Analysts Conflicted on These Technology Names: Broadcom (AVGO), NICE (NICE) and Science Applications (SAIC)

TIPRANKS
·
13 Dec 2024

Monterey County District Attorney's Office Selects NICE Justice AI-powered Digital Evidence Management

Business Wire
·
12 Dec 2024

SABCS 2024: New Research Assesses iCAD’s Image Based AI-Risk, Detection, and Breast Arterial Calcifications (BAC) Assessment Across Diverse Populations

GlobeNewswire
·
11 Dec 2024

Fulton Bank Revolutionizes Financial Services Interactions with NICE CXone Mpower Copilot and Autopilot

Business Wire
·
11 Dec 2024

How NICE Ltd. (NICE) Is Helping Prosper Reimagine the Customer Experience with AI

Insider Monkey
·
10 Dec 2024

Santhera Receives Positive Recommendation from NICE for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy

GlobeNewswire
·
10 Dec 2024

Prosper Creates Exceptional CX with Industry-Leading NICE CXone Mpower

Business Wire
·
09 Dec 2024

IMFINZI® (durvalumab) granted Priority Review in the US ​for patients with muscle-invasive bladder cancer

Business Wire
·
06 Dec 2024

Travel + Leisure Co. Optimizes Vacation Ownership CX with NICE CXone Mpower

Business Wire
·
05 Dec 2024

NICE Unveils AI Tool for Real-Time Multilingual Communication

TIPRANKS
·
05 Dec 2024

Clean Energy Inks New Renewable Natural Gas Deals With Cross-Industry Customers Seeking a Sustainable, Clean Fuel

Business Wire
·
05 Dec 2024

Broyhill Capital Management Views AI as an Enabler of Growth with New Revenue Sources for Nice Ltd (NICE)

Insider Monkey
·
04 Dec 2024

NICE Reports 80% YOY Increase in Digital Interactions for Retailers Over Black Friday and Cyber Monday Shopping Weekend

Business Wire
·
04 Dec 2024

Outlook Therapeutics announces NICE recommendation of LYTENAVA

TIPRANKS
·
04 Dec 2024

Outlook Therapeutics® Announces NICE Recommendation of LYTENAVA™ (bevacizumab gamma) for the Treatment of Wet AMD

GlobeNewswire
·
04 Dec 2024

NICE Releases Environmental, Social and Governance (ESG) Report, Showcasing Power of Automation in Driving Exceptional Experiences

Business Wire
·
04 Dec 2024

EGHT Rises 38% in a Month: Is the Stock Still a Screaming Buy?

Zacks
·
03 Dec 2024

Immunocore Says UK NICE Recommends Kimmtrak for Funding Through National Health Service in England

MT Newswires Live
·
03 Dec 2024

Great Southern Bank Reduced Customer Wait Times With NICE CXone Mpower

Business Wire
·
03 Dec 2024

Rhythm Pharmaceuticals Announces ▼ IMCIVREE® (setmelanotide) Receives Expanded Marketing Authorization in the United Kingdom for Treatment of Obesity and Control of Hunger in Patients with Bardet Biedl Syndrome or POMC, PCSK1, or LEPR Deficiency to include Children as Young as 2 Years Old

GlobeNewswire
·
03 Dec 2024